Fortis Malar [FORTISMLR] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison

Fortis Malar

BSE
Loading...

Indraprastha Medical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fortis Malar wins in 8 metrics, Indraprastha Medical wins in 11 metrics, with 0 ties. Indraprastha Medical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFortis MalarIndraprastha MedicalBetter
P/E Ratio (TTM)26.3625.25Indraprastha Medical
Price-to-Book Ratio4.027.11Fortis Malar
Debt-to-Equity Ratio0.005.49Fortis Malar
PEG Ratio0.001.69Fortis Malar
EV/EBITDA154.2915.61Indraprastha Medical
Profit Margin (TTM)22,483.90%12.21%Fortis Malar
Operating Margin (TTM)-1,572.20%17.25%Indraprastha Medical
EBITDA Margin (TTM)N/A17.25%N/A
Return on Equity1.30%26.98%Indraprastha Medical
Return on Assets (TTM)1.06%18.90%Indraprastha Medical
Free Cash Flow (TTM)$15.44M$1.20BIndraprastha Medical
Dividend Yield3.38%0.95%Fortis Malar
1-Year Return28.02%6.14%Fortis Malar
Price-to-Sales Ratio (TTM)5,928.803.09Indraprastha Medical
Enterprise Value$893.16M$39.53BIndraprastha Medical
EV/Revenue Ratio4,356.882.88Indraprastha Medical
Gross Profit Margin (TTM)100.00%38.19%Fortis Malar
Revenue per Share (TTM)$0$150Indraprastha Medical
Earnings per Share (Diluted)$2.46$18.31Indraprastha Medical
Beta (Stock Volatility)-0.100.57Fortis Malar
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fortis Malar vs Indraprastha Medical Stock Performance Analysis

Loading Price Chart...

Fortis Malar
Indraprastha Medical
Fortis Malar Stock Overview | Indraprastha Medical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fortis Malar12.88%13.38%6.95%2.06%-4.30%18.75%
Indraprastha Medical3.40%8.16%0.29%-5.98%25.53%-11.75%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fortis Malar28.02%30.02%52.82%60.70%103.62%520.34%
Indraprastha Medical6.14%663.13%858.12%620.03%933.73%964.81%

News Based Sentiment: Fortis Malar vs Indraprastha Medical

Fortis Malar

News based Sentiment: MIXED

October brought a mix of developments for Fortis Malar, with a key regulatory approval for a potential ownership change alongside improving, but still negative, financial results. The insider trading activity adds a layer of intrigue, suggesting someone believes in the company's future, but the overall picture remains complex.

View Fortis Malar News Sentiment Analysis

Indraprastha Medical

News based Sentiment: MIXED

The company reported strong financial results for Q1 FY25, but is facing bearish technical trends and trades at a discount to its peers. While the new product launch and increased FII holding are positive signs, the mixed signals create a cautious outlook for investors.

View Indraprastha Medical News Sentiment Analysis

Performance & Financial Health Analysis: Fortis Malar vs Indraprastha Medical

MetricFORTISMLRINDRAMEDCO
Market Information
Market Cap i₹1.22B₹42.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i13,891116,540
90 Day Avg. Volume i15,957206,667
Last Close₹73.20₹478.10
52 Week Range₹55.15 - ₹98.70₹307.25 - ₹572.00
% from 52W High-25.84%-16.42%
All-Time High₹107.94 (Apr 22, 2024)₹572.00 (Jan 06, 2025)
% from All-Time High-32.18%-16.42%
Growth Metrics
Quarterly Revenue GrowthN/A0.05%
Quarterly Earnings GrowthN/A0.15%
Financial Health
Profit Margin (TTM) i224.84%0.12%
Operating Margin (TTM) i-15.72%0.17%
Return on Equity (TTM) i0.01%0.27%
Debt to Equity (MRQ) i0.005.49
Cash & Liquidity
Book Value per Share (MRQ)₹16.12₹65.04
Cash per Share (MRQ)₹17.19₹35.08
Operating Cash Flow (TTM) i₹-10,605,000₹1.78B
Levered Free Cash Flow (TTM) i₹3.92M₹1.61B
Dividends
Last 12-Month Dividend Yield i3.38%0.95%
Last 12-Month Dividend i₹2.50₹4.50

Valuation & Enterprise Metrics Analysis: Fortis Malar vs Indraprastha Medical

MetricFORTISMLRINDRAMEDCO
Price Ratios
P/E Ratio (TTM) i26.3625.25
Forward P/E iN/A184.96
PEG Ratio i0.001.69
Price to Sales (TTM) i5,928.803.09
Price to Book (MRQ) i4.027.11
Market Capitalization
Market Capitalization i₹1.22B₹42.43B
Enterprise Value i₹893.16M₹39.53B
Enterprise Value Metrics
Enterprise to Revenue i4,356.882.88
Enterprise to EBITDA i154.2915.61
Risk & Other Metrics
Beta i-0.100.57
Book Value per Share (MRQ) i₹16.12₹65.04

Financial Statements Comparison: Fortis Malar vs Indraprastha Medical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FORTISMLRINDRAMEDCO
Revenue/Sales i₹205,000₹3.65B
Cost of Goods Sold i₹0₹2.26B
Gross Profit i₹205,000₹1.39B
Research & Development iN/AN/A
Operating Income (EBIT) i₹42.85M₹629.70M
EBITDA i₹42.85M₹800.50M
Pre-Tax Income i₹42.85M₹683.10M
Income Tax i₹1.32M₹168.50M
Net Income (Profit) i₹41.53M₹514.60M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FORTISMLRINDRAMEDCO
Cash & Equivalents i₹2.02M₹614.80M
Total Current Assets i₹341.12M₹4.31B
Total Current Liabilities i₹66.23M₹1.79B
Long-Term Debt iN/A₹305.40M
Total Shareholders Equity i₹302.09M₹5.97B
Retained Earnings i₹18.80M₹4.75B
Property, Plant & Equipment i₹0₹2.60B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FORTISMLRINDRAMEDCO
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFORTISMLRINDRAMEDCO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i13,891116,540
Average Daily Volume (90 Day) i15,957206,667
Shares Outstanding i18.74M91.67M
Float Shares i4.83M41.01M
% Held by Insiders i0.72%0.58%
% Held by Institutions i0.00%0.03%

Dividend Analysis & Yield Comparison: Fortis Malar vs Indraprastha Medical

MetricFORTISMLRINDRAMEDCO
Last 12-Month Dividend i₹2.50₹4.50
Last 12-Month Dividend Yield i3.38%0.95%
3-Year Avg Annual Dividend i₹14.17₹4.00
3-Year Avg Dividend Yield i26.20%1.26%
3-Year Total Dividends i₹42.50₹12.00
Ex-Dividend DateJul 24, 2024Sep 18, 2025